Liaoning Gerui Shite Bio-Pharmaceutical

Liaoning Gerui Shite Bio-Pharmaceutical is a Chinese biotechnology company focused on the research, development, and production of long-acting recombinant protein drugs. The company leverages its proprietary PEGylation technology platform to create modified biologics with improved pharmacokinetic profiles and reduced dosing frequency. Its primary commercial product is a long-acting recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) designed to prevent and treat neutropenia in cancer patients undergoing chemotherapy. Additionally, the company is advancing a pipeline of long-acting interferons and other therapeutic proteins for infectious diseases and oncology. Gerui Shite operates a large-scale GMP manufacturing base in the Benxi High-tech Zone, positioning itself as a key player in the regional biopharmaceutical sector.